FLT3 anticorps (AA 589-593)
Aperçu rapide pour FLT3 anticorps (AA 589-593) (ABIN362818)
Antigène
Voir toutes FLT3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 589-593
-
Specificité
- The antibody detects endogenous level of total FLT3 protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
-
Immunogène
- Peptide sequence around AA 589-593 (Y-F-Y-V-D) derived from Human FLT3. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Western blotting: 1:500-1:1000
Immunofluorescence: 1:100-1:200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
-
: "Mesenchymal stem cells originating from ES cells show high telomerase activity and therapeutic benefits." dans: Differentiation; research in biological diversity, Vol. 82, Issue 3, pp. 153-64, (2011) (PubMed).
: "Does emotional disclosure have any effects? A systematic review of the literature with meta-analyses." dans: International journal of technology assessment in health care, Vol. 21, Issue 2, pp. 153-64, (2005) (PubMed).
-
-
- FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
-
Autre désignation
- FLT3
-
Sujet
- FLT3 encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
-
Poids moléculaire
- 160 kDa
-
NCBI Accession
- NP_004110
-
UniProt
- P36888
-
Pathways
- Signalisation RTK
Antigène
-